The free falling cost of whole genome sequencing raises the possibility – some say the inevitability – of applying this revolutionary technology in the clinic. More and more medical geneticists are proposing the idea of a "sequence once, read often" approach to preventive medicine. However, huge challenges spanning the scientific, regulatory, ethical and financial arena's stand in the way of clinical genome sequencing becoming part of mainstream medicine. Unlike the research world, clinicians need efficient and repeatable processes, but are confronted by a plethora of platforms, software tools, and databases, and few if any best practices in interpreting, storing and sharing a patient's genome data. Cambridge Healthtech Institute and Bio-IT World are proud to announce TCGC: The Clinical Genome Conference, inviting stakeholders from all arenas impacting clinical genomics to share new findings and solutions in advancing the application of clinical genome sequencing.
- Roads to Regulation & Certification
- Prepare Now for Reimbursement
- Impact of Direct-to-Consumer Tests
- Issues with Returning WGS Results